C-terminal binding protein-2 triggers CYR61-induced metastatic dissemination of osteosarcoma in a non-hypoxic microenvironment
Abstract Background Osteosarcoma is the most prevalent cancer-related bone disease diagnosed in the pediatric age group. The rapid development of metastatic lesions and resistance to chemotherapy remain major mechanisms responsible for the failure of treatments and poor outcome. We established that...
Saved in:
| Main Authors: | Laura Di Patria, Nadia Habel, Robert Olaso, Romain Fernandes, Catherine Brenner, Bojana Stefanovska, Olivia Fromigue |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | Journal of Experimental & Clinical Cancer Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13046-025-03350-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CYR61 as a Potential Biomarker and Target in Cancer Prognosis and Therapies
by: Andrew J. Schenker, et al.
Published: (2025-05-01) -
The value of urinary cysteine rich protein 61 in early diagnosis of contrast-induced nephropathy
by: XIE Juan, et al.
Published: (2019-01-01) -
The multifunctional protein CCN1/CYR61: Bridging physiology and disease
by: Racha Kerek, et al.
Published: (2025-06-01) -
Genes Related to Motility in an Ionizing Radiation and Estrogen Breast Cancer Model
by: Tania Koning, et al.
Published: (2024-10-01) -
Endosialin promotes vascular maturation by inhibiting Cyr61 expression in melanoma metastasis
by: Tong Lu, et al.
Published: (2025-07-01)